Oncology & Cancer Oral Drug Market Report

China Oncology & Cancer Oral Drug Industry Market Research Report 2023-2029

  • POSTDATE：Sep 13, 2023
  • PAGES：226
  • REPORT CODE：GMM1796001
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Oncology & Cancer Oral Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Amgen

    • Pfizer

    • Novartis

    • AstraZeneca

    • Eli Lilly

    • Bristol-Myers Squibb

    • Roche

    • Johnson & Johnson

    • AbbVie

    • Celgene

    • Biogen Idec

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Blood Cancer

    • Breast Cancer

    • Others

    • Prostate Cancer

    • Gastrointestinal Cancer

    • Respiratory/Lung Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oncology & Cancer Oral Drug Market Overview 2018-2029

    • 1.1 China Oncology & Cancer Oral Drug Industry Development Overview

    • 1.2 China Oncology & Cancer Oral Drug Industry Development History

    • 1.3 China Oncology & Cancer Oral Drug Industry Market Size (2018-2029)

    • 1.4 China Oncology & Cancer Oral Drug Market Analysis by Type from Production Side

      • 1.4.1 China Oncology & Cancer Oral Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Oncology & Cancer Oral Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Oncology & Cancer Oral Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Oncology & Cancer Oral Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

      • 1.5.2 China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.3 China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)

      • 1.5.5 China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Gastrointestinal Cancer (2018-2029)

      • 1.5.6 China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Respiratory/Lung Cancer (2018-2029)

    • 1.6 China Oncology & Cancer Oral Drug Market Analysis by Region

      • 1.6.1 North China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oncology & Cancer Oral Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oncology & Cancer Oral Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oncology & Cancer Oral Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Oncology & Cancer Oral Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oncology & Cancer Oral Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oncology & Cancer Oral Drug Industry Development

    Chapter 3 Oncology & Cancer Oral DrugIndustry Chain Analysis

    • 3.1 Oncology & Cancer Oral Drug Industry Chain

    • 3.2 Oncology & Cancer Oral Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oncology & Cancer Oral Drug Market

    • 3.3 Oncology & Cancer Oral Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oncology & Cancer Oral Drug Market

    Chapter 4 China Oncology & Cancer Oral Drug Market, by Type

    • 4.1 China Oncology & Cancer Oral Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oncology & Cancer Oral Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oncology & Cancer Oral Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Oncology & Cancer Oral Drug Production Volume and Growth Rate of Type 1

      • 4.5.2 China Oncology & Cancer Oral Drug Production Volume and Growth Rate of Type 2

      • 4.5.3 China Oncology & Cancer Oral Drug Production Volume and Growth Rate of Type 3

    Chapter 5 China Oncology & Cancer Oral Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oncology & Cancer Oral Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oncology & Cancer Oral Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Oncology & Cancer Oral Drug Market Size and Growth Rate of Blood Cancer

      • 5.5.2 China Oncology & Cancer Oral Drug Market Size and Growth Rate of Breast Cancer

      • 5.5.3 China Oncology & Cancer Oral Drug Market Size and Growth Rate of Others

      • 5.5.4 China Oncology & Cancer Oral Drug Market Size and Growth Rate of Prostate Cancer

      • 5.5.5 China Oncology & Cancer Oral Drug Market Size and Growth Rate of Gastrointestinal Cancer

      • 5.5.6 China Oncology & Cancer Oral Drug Market Size and Growth Rate of Respiratory/Lung Cancer

    Chapter 6 China Oncology & Cancer Oral Drug Market, by Region

    • 6.1 China Oncology & Cancer Oral Drug Production Volume and Production Value, by Region

    • 6.2 China Oncology & Cancer Oral Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Oncology & Cancer Oral Drug Market Analysis

    • 7.1 North China Oncology & Cancer Oral Drug Market, by Type

    • 7.2 North China Oncology & Cancer Oral Drug Market, by Application

    Chapter 8 Central China Oncology & Cancer Oral Drug Market Analysis

    • 8.1 Central China Oncology & Cancer Oral Drug Market, by Type

    • 8.2 Central China Oncology & Cancer Oral Drug Market, by Application

    Chapter 9 South China Oncology & Cancer Oral Drug Market Analysis

    • 9.1 South China Oncology & Cancer Oral Drug Market, by Type

    • 9.2 South China Oncology & Cancer Oral Drug Market, by Application

    Chapter 10 East China Oncology & Cancer Oral Drug Market Analysis

    • 10.1 East China Oncology & Cancer Oral Drug Market, by Type

    • 10.2 East China Oncology & Cancer Oral Drug Market, by Application

    Chapter 11 Northeast China Oncology & Cancer Oral Drug Market Analysis

    • 11.1 Northeast China Oncology & Cancer Oral Drug Market, by Type

    • 11.2 Northeast China Oncology & Cancer Oral Drug Market, by Application

    Chapter 12 Southwest China Oncology & Cancer Oral Drug Market Analysis

    • 12.1 Southwest China Oncology & Cancer Oral Drug Market, by Type

    • 12.2 Southwest China Oncology & Cancer Oral Drug Market, by Application

    Chapter 13 Northwest China Oncology & Cancer Oral Drug Market Analysis

    • 13.1 Northwest China Oncology & Cancer Oral Drug Market, by Type

    • 13.2 Northwest China Oncology & Cancer Oral Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Amgen

        • 14.1.1 Amgen Company Profile

        • 14.1.2 Amgen Oncology & Cancer Oral Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer

        • 14.2.1 Pfizer Company Profile

        • 14.2.2 Pfizer Oncology & Cancer Oral Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Novartis

        • 14.3.1 Novartis Company Profile

        • 14.3.2 Novartis Oncology & Cancer Oral Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 AstraZeneca

        • 14.4.1 AstraZeneca Company Profile

        • 14.4.2 AstraZeneca Oncology & Cancer Oral Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Eli Lilly

        • 14.5.1 Eli Lilly Company Profile

        • 14.5.2 Eli Lilly Oncology & Cancer Oral Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bristol-Myers Squibb

        • 14.6.1 Bristol-Myers Squibb Company Profile

        • 14.6.2 Bristol-Myers Squibb Oncology & Cancer Oral Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Roche

        • 14.7.1 Roche Company Profile

        • 14.7.2 Roche Oncology & Cancer Oral Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Johnson & Johnson

        • 14.8.1 Johnson & Johnson Company Profile

        • 14.8.2 Johnson & Johnson Oncology & Cancer Oral Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 AbbVie

        • 14.9.1 AbbVie Company Profile

        • 14.9.2 AbbVie Oncology & Cancer Oral Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Celgene

        • 14.10.1 Celgene Company Profile

        • 14.10.2 Celgene Oncology & Cancer Oral Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Biogen Idec

        • 14.11.1 Biogen Idec Company Profile

        • 14.11.2 Biogen Idec Oncology & Cancer Oral Drug Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oncology & Cancer Oral Drug Industry Research Conclusions

    • 15.2 Oncology & Cancer Oral Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oncology & Cancer Oral Drug Industry Market Size (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Gastrointestinal Cancer (2018-2029)

    • Figure China Oncology & Cancer Oral Drug Sales Volume, Sales Value and Growth Rate of Respiratory/Lung Cancer (2018-2029)

    • Figure North China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oncology & Cancer Oral Drug Market Size and Growth Rate from 2018-2029

    • Figure Oncology & Cancer Oral Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oncology & Cancer Oral Drug Market Share by Type in 2018

    • Figure China Oncology & Cancer Oral Drug Market Share by Type in 2023

    • Figure China Oncology & Cancer Oral Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Market Share by Application in 2018

    • Figure China Oncology & Cancer Oral Drug Market Share by Application in 2023

    • Figure China Oncology & Cancer Oral Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Oncology & Cancer Oral Drug Market Size and Growth Rate of Blood Cancer (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Market Size and Growth Rate of Others (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Market Size and Growth Rate of Prostate Cancer (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Market Size and Growth Rate of Gastrointestinal Cancer (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Market Size and Growth Rate of Respiratory/Lung Cancer (2018-2023)

    • Table China Oncology & Cancer Oral Drug Production Volume by Region (2018-2023)

    • Table China Oncology & Cancer Oral Drug Production Volume Share by Region (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Production Volume Share by Region (2018-2023)

    • Table China Oncology & Cancer Oral Drug Production Value by Region (2018-2023)

    • Table China Oncology & Cancer Oral Drug Production Value Share by Region (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Production Value Share by Region (2018-2023)

    • Table China Oncology & Cancer Oral Drug Sales Volume by Region (2018-2023)

    • Table China Oncology & Cancer Oral Drug Sales Volume Share by Region (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Sales Volume Share by Region (2018-2023)

    • Table China Oncology & Cancer Oral Drug Sales Value by Region (2018-2023)

    • Table China Oncology & Cancer Oral Drug Sales Value Share by Region (2018-2023)

    • Figure China Oncology & Cancer Oral Drug Sales Value Share by Region (2018-2023)

    • Table North China Oncology & Cancer Oral Drug Production Volume by Type (2018-2023)

    • Table North China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Figure North China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Table North China Oncology & Cancer Oral Drug Sales Volume by Application (2018-2023)

    • Table North China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Oncology & Cancer Oral Drug Production Volume by Type (2018-2023)

    • Table Central China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Table Central China Oncology & Cancer Oral Drug Sales Volume by Application (2018-2023)

    • Table Central China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Table South China Oncology & Cancer Oral Drug Production Volume by Type (2018-2023)

    • Table South China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Figure South China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Table South China Oncology & Cancer Oral Drug Sales Volume by Application (2018-2023)

    • Table South China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Table East China Oncology & Cancer Oral Drug Production Volume by Type (2018-2023)

    • Table East China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Figure East China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Table East China Oncology & Cancer Oral Drug Sales Volume by Application (2018-2023)

    • Table East China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oncology & Cancer Oral Drug Production Volume by Type (2018-2023)

    • Table Northeast China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Oncology & Cancer Oral Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oncology & Cancer Oral Drug Production Volume by Type (2018-2023)

    • Table Southwest China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Oncology & Cancer Oral Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oncology & Cancer Oral Drug Production Volume by Type (2018-2023)

    • Table Northwest China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oncology & Cancer Oral Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Oncology & Cancer Oral Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oncology & Cancer Oral Drug Sales Volume Share by Application (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table Celgene Company Profile

    • Table Celgene Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)

    • Table Biogen Idec Company Profile

    • Table Biogen Idec Oncology & Cancer Oral Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US